UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3D co-cultures of epithelial cells with immune cells as a model of HSV and oncolytic HSV infections

Access microbiology, 2020-07, Vol.2 (7A)

2020

Volltextzugriff (PDF)

Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (19_Supplement), p.A08-A08

2018

Volltextzugriff (PDF)

Abstract A14: Checkpoinblockade enhances oncolytic herpes virotherapy in immunosuppressive sarcoma models

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5_Supplement), p.A14-A14

2016

Volltextzugriff (PDF)

Abstract B049: Evaluation of attenuated HSV1716 in combination with chimeric antigen receptor T cells for solid tumors

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B049-B049

2016

Volltextzugriff (PDF)

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility

Gene therapy, 2016-02, Vol.23 (2), p.135-143

2016

Volltextzugriff (PDF)

Development of a Trojan horse oncolytic virus for treatment of myeloma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14035-e14035

2015

Volltextzugriff (PDF)

Please stand by: how oncolytic viruses impact bystander cells

Future virology, 2018-09, Vol.13 (9), p.671-680

2018

Volltextzugriff (PDF)

Abstract B033: Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR® in patients with malignant pleural mesothelioma

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B033-B033

2016

Volltextzugriff (PDF)

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

Oncotarget, 2017-03, Vol.8 (11), p.17412-17427

2017

Volltextzugriff (PDF)

666. Oncolytic Herpes Virotherapy Induces a Paracrine Death Signal Causing Synergistic Antitumor Efficacy with Aurora A Kinase Inhibition

Molecular therapy, 2016-05, Vol.24, p.S263-S264

2016

Volltextzugriff (PDF)

In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy

Journal of Nuclear Medicine, 2012-04, Vol.53 (4), p.647-654

2012

Volltextzugriff (PDF)

Abstract B35: Enhanced antitumor efficacy by combining oncolytic herpes simplex virus and Aurora A kinase inhibition in models of neuroblastoma and malignant peripheral nerve sheath tumor

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5_Supplement), p.B35-B35

2016

Volltextzugriff (PDF)

Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P335-P335

2015

Volltextzugriff (PDF)

432. Aurora A Kinase Inhibition Enhances Oncolytic Herpes Simplex Virotherapy in Models of Neuroblastoma

Molecular therapy, 2015-05, Vol.23, p.S171-S171

2015

Volltextzugriff (PDF)

A phase I dose-escalation study of intratumoral herpes simplex virus-1 mutant HSV1716 in pediatric/young adult patients with refractory non-central nervous system solid tumors

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10047-10047

2013

Volltextzugriff (PDF)

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Journal of hepatocellular carcinoma, 2014-01, Vol.1 (Issue 1), p.149-161

2014

Volltextzugriff (PDF)

The unique N terminus of herpes simplex virus type 1 ribonucleotide reductase large subunit is phosphorylated by casein kinase 2, which may have a homologue in Escherichia coli

Journal of general virology, 1999-06, Vol.80 (6), p.1471-1476

Conner, J

1999

Volltextzugriff (PDF)

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

Brain (London, England : 1878), 2001-05, Vol.124 (5), p.893-906

2001

Volltextzugriff (PDF)

Use of magnetic resonance targeting to steer ov-loaded cell-based therapies to tumor sites in vivo

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P339-P339, Article P339

2015

Volltextzugriff (PDF)

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations

The Journal of clinical investigation, 1999-09, Vol.104 (6), p.697-708

1999

Volltextzugriff (PDF)

New Collaborations With Native Americans in the Conduct of Community Research

Health education & behavior, 2006-04, Vol.33 (2), p.148-153

2006

Volltextzugriff (PDF)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs

Oncolytic virotherapy, 2013-01, Vol.2, p.57-74

2013

Volltextzugriff (PDF)

Commentary: New Collaborations With Native Americans in the Conduct of Community Research

Health education & behavior, 2006-04, Vol.33 (2), p.148-153

2006

Volltextzugriff (PDF)

Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire

Journal of neuroimmunology, 2005-08, Vol.165 (1), p.92-103

2005

Volltextzugriff (PDF)

A review of improved ethical practices in environmental and public health research : Case examples from native communities. Commentary

Health education & behavior, 2006, Vol.33 (2), p.130-153

2006

Volltextzugriff (PDF)

26 – 50 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(85)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(46)
Humans
(24)
Animals
(22)
Biological And Medical Sciences
(16)
Mice
(14)
Female
(13)
Male
(13)
Tumors
(11)
Virology
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Herpes Simplex Virus 1
(9)
Oncology
(9)
Oncolysis
(9)
Herpes Simplex
(8)
Molecular Sequence Data
(8)
Oncolytic Virus
(8)
Adult
(7)
Cancer
(7)
Medical Sciences
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

3D co-cultures of epithelial cells with immune cells as a model of HSV and oncolytic HSV infections

Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma

Abstract A14: Checkpoinblockade enhances oncolytic herpes virotherapy in immunosuppressive sarcoma models

Abstract B049: Evaluation of attenuated HSV1716 in combination with chimeric antigen receptor T cells for solid tumors

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility

Development of a Trojan horse oncolytic virus for treatment of myeloma

Please stand by: how oncolytic viruses impact bystander cells

Abstract B033: Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR® in patients with malignant pleural mesothelioma

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

666. Oncolytic Herpes Virotherapy Induces a Paracrine Death Signal Causing Synergistic Antitumor Efficacy with Aurora A Kinase Inhibition

In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy

Abstract B35: Enhanced antitumor efficacy by combining oncolytic herpes simplex virus and Aurora A kinase inhibition in models of neuroblastoma and malignant peripheral nerve sheath tumor

Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma

432. Aurora A Kinase Inhibition Enhances Oncolytic Herpes Simplex Virotherapy in Models of Neuroblastoma

A phase I dose-escalation study of intratumoral herpes simplex virus-1 mutant HSV1716 in pediatric/young adult patients with refractory non-central nervous system solid tumors

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

The unique N terminus of herpes simplex virus type 1 ribonucleotide reductase large subunit is phosphorylated by casein kinase 2, which may have a homologue in Escherichia coli

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

Use of magnetic resonance targeting to steer ov-loaded cell-based therapies to tumor sites in vivo

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations

New Collaborations With Native Americans in the Conduct of Community Research

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs

Commentary: New Collaborations With Native Americans in the Conduct of Community Research

Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire

A review of improved ethical practices in environmental and public health research : Case examples from native communities. Commentary

Suchergebnisse filtern